Previous Page  11 / 22 Next Page
Information
Show Menu
Previous Page 11 / 22 Next Page
Page Background

Notes:

Page 65

Euro Biotechnology 2016

November 07-09, 2016

Volume 6, Issue 7(Suppl)

J Biotechnol Biomater

ISSN: 2155-952X JBTBM, an open access journal

conferenceseries

.com

November 07-09, 2016 Alicante, Spain

12

th

Euro Biotechnology Congress

Meeyoung Lee, J Biotechnol Biomater 2016, 6:7(Suppl)

http://dx.doi.org/10.4172/2155-952X.C1.065

Safety assessment of Guibi-tang: Subchronic toxicity study in Crl:CD SD rats

Meeyoung Lee

Korea Institute of Oriental Medicine, South Korea

G

uibi-tang (Kihi-To in Japanese and Qui-Pi-Tang in Chinese) is a multiherbal traditional Korean medicinal formula used

for treatment of amnesia, fatigue, poor memory or forgetfulness, anemia, insomnia and necrosis. The aim of the present

study was to investigate potential safety, if any, of subchronic administration of Guibi-tang aqueous extract (GBT) in laboratory

animals. For this study, 0, 1000, 2000 and 5000 mg/kg/day of GBT was administered to Crl:CD Sprague Dawley rats (10/sex/

group) for 13 weeks via oral gavage. Administration of the GBT did not result in any mortality, body weight, food consumption,

hematology, serum biochemistry, clinical or ophthalmological signs or changes in urinalysis, gross findings or organ weight.

However, histopathology revealed forestomach hyperplasia and duodenum mucosal hyperplasia in rats of both sexes at the

highest dose of GBT, 5000 mg/kg/day. Therefore, the no-observed-adverse-effect level in rats was established for GBT at 2000

mg/kg/day under the conditions of this study.

Biography

Meeyoung Lee has completed his Master’s and Doctor’s degree from the College of Veterinary Medicine, Chungnam National University. He is the Researcher

working in K-herb Research Center of Korea Institute of Oriental Medicine. She has published more than 10 papers in reputed journals.

cozy11@kiom.re.kr